1997

(BW) (UCSF/AIDS) Disease that Struck Troops in World War I Has Come Back to Threaten Lives of Homeless AIDS Patients: BUSINESS WIRE; Wednesday, December 24, 1997; SAN FRANCISCO--(BW HealthWire)--Dec. 24, 1997--A bacterial infection that afflicted tens of thousands of soldiers in the trenches during the first World War is making a comeback of sorts, threatening the lives of homeless AIDS patients. The discovery was made by a research team led by Jane Koehler, MD, a microbiologist
(BW) State of California To Pay $1.45 Million to Settle AIDS Healthcare Foundation Lawsuit: BUSINESS WIRE; Tuesday December 23, 6:06 pm EST; LOS ANGELES--(BUSINESS WIRE)--Dec. 23, 1997--The state of California has agreed to pay $800,000 to settle a lawsuit brought by AIDS Healthcare Foundation (AHF) for managed care services it provided, and to make additional future payments totaling $1.45 million. This settlement guarantees the viability of our innovative
(BW) Saliva Diagnostic Systems Demonstrates StatSimple pylori in Europe: BUSINESS WIRE; Thursday December 11, 8:04 am EST; VANCOUVER, Wash.--(BUSINESS WIRE)--Dec. 11, 1997--Saliva Diagnostic Systems, Inc. (Nasdaq: SALV - news, SALVW - news) demonstrated its latest rapid test, StatSimple(TM) pylori, in Europe at the recent Medica trade show in Dusseldorf, Germany . StatSimple pylori is a self-contained system for the collection, processing
(BW) UCSF/Mount Zion Seeks Patients for Pain Management Study Evaluating Chili Pepper Treatment: BUSINESS WIRE; Wednesday December 10, 4:51 pm EST; SAN FRANCISCO--(BW HealthWire)--Dec. 10, 1997--People who are experiencing severe burning foot pain associated with HIV may participate in a UCSF clinical trial that is evaluating a treatment derived from chili peppers. The study, conducted by Wendye Robbins, M.D., UCSF assistant clinical professor of anesthesiology, i
(BW) (NEXSTAR-PHARMACEUTICALS)(NXTR) New AmBisome Data Released at National Hematology Meeting: BUSINESS WIRE; Wednesday, December 10, 1997; SAN DIEGO--(BW HealthWire)--Dec. 10, 1997--NeXstar Pharmaceuticals Inc. (NASDAQ: NXTR) announced today that independent investigators presented new data supporting AmBisome (liposomal amphotericin B), the company s proprietary anti-fungal product. AmBisome is cleared for use in the United States as empirical therap
(BW) (UCSF/GLIDE-FREE-CLINIC) ADVISORY/Glide Memorial Church Partners with UCSF; Catholic Healthcare West-West Bay Region to Open Free Health Care Clinic: BUSINESS WIRE; Saturday, December 6, 1997; News & Assignment Editors/Health & Medical Writers ADVISORY...for 11:00 a.m., Sunday (Dec. 7) A new clinic that reaches out to the underserved residents of one of San Francisco s most blighted neighborhoods will officially open at Glide Memorial United Methodist Church Sunday. Media Are Invited to Cover: Sunday
(BW) Home Access Health World AIDS Day Observance Encourages Thousands of People To Test for HIV: BUSINESS WIRE; Thursday December 4, 12:26 pm EST; HOFFMAN ESTATES, Ill.--(BW HealthWire)--Dec. 4, 1997--Thousands of people responded to the offer of a free Home Access(R) Express(TM) HIV test as part of a special 24-hour World AIDS Day observance conducted by Home Access Health Corporation, the leader in telemedicine. In just 24 hours, the Company received nearly $10
(BW) (GILEAD-SCIENCES)(GILD) Gilead Sciences Announces Start of Expanded Access Program for PREVEON; An Investigational, Once-Daily Treatment for HIV Available to Patients with Limited Treatment Options: BUSINESS WIRE; Thursday, December 4, 1997.; FOSTER CITY, Calif.--(BW HealthWire)--Dec. 4, 1997-- Gilead Sciences , Inc. (NASDAQ:GILD) today announced an expanded access program for PREVEON(TM) (adefovir dipivoxil) for people with advanced HIV infection in the United States who have limited treatment options. PREVEON, formerly referred to as adefovir dipivoxil o
(BW) Home Access Health Issues First Published Account of National HIV Seroprevalence and Demographic Data Among Home Test Users; Data suggests that HIV at-home testing is used by people at risk for HIV and first time testers: BUSINESS WIRE; Monday, December 1, 1997.; HOFFMAN ESTATES, Ill.--(BW HealthWire)--Dec. 1, 1997-- The first published account of national HIV seroprevalence and demographic data among home test users was issued today by Home Access Health Corporation, the only company that provides an over-the-counter, FDA approved HIV at-home test available nationwide in more
(BW) S.F. AIDS Foundation re-launches expanded and enhanced web site on World AIDS Day; www.sfaf.org features more than 400 original articles, reports and images: BUSINESS WIRE; Friday November 28, 9:36 am Eastern Time; SAN FRANCISCO--(BUSINESS WIRE)--Nov. 28, 1997--To commemorate World AIDS Day, the San Francisco AIDS Foundation is re-launching its newly expanded and graphically enhanced web site at www.sfaf.org, featuring more than 400 original articles, reports and images. The San Francisco AIDS Foundation s newly expanded and enha
(BW) World AIDS Day To Focus On Children: BUSINESS WIRE; Wednesday November 26, 3:46 pm Eastern Time; ATLANTA--(BUSINESS WIRE)--Nov. 26, 1997--Georgia has the tenth highest number of children with AIDS in the country, 176, since 1980. Ninety-one percent of these children contracted the HIV virus from their mother during pregnancy, birth or through breastfeeding. Give Children Hope in a World with AIDS, is the theme of
(BW) (HIV-RESOURCE-PACKETS) State Provides HIV Educational Materials to Perinatal Providers; California Aims to Prevent AIDS in the Next Generation Through Education and Counseling to Pregnant Women: BUSINESS WIRE; Wednesday, November 26, 1997.; SACRAMENTO, Calif.--(BW HealthWire)--November 26, 1997--In recognition of World AIDS Day and its focus on children this year, State Health Director Kim Belshe Wednesday announced that the Department of Health Services is collaborating with the federal Health Care Financing Administration (HCFA) to develop and distribut
(BW) (WORLD-AIDS-DAY) World Aids Day Editorial: BUSINESS WIRE; Wednesday, November 26, 1997.; SEATTLE--(BUSINESS WIRE)--Nov. 26, 1997--The attached editorial was written by Dr. Maxine Hayes, assistant secretary for community and family health, state Department of Health. On December 1st, we commemorate the 9th annual World AIDS Day. The day was set forth by the Joint United Nations Program on HIV/AIDS to increa
(BW) (CALIF-DEPT-HEALTH/AIDS) ADVANCE/HIV/AIDS: Fact vs. Fiction: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 25 November 1997.; (ADVANCE) SACRAMENTO, Calif.--(BW HealthWire)--Dec. 1, 1997-- While recent advances in treatment have given new hope to many people living with HIV and AIDS, prevention is still the most effective weapon in the fight against AIDS. Do you really know the facts about HIV/AIDS? Put yourself to the test and find out. 1
(BW) (SEQUUS-PHARMACEUTICALS)(SEQU) SEQUUS Pharmaceuticals, Inc. Signs Marketing Agreement for AMPHOCIL in South Asia with CritiCare Laboratories Pvt. Ltd.: BUSINESS WIRE; Tuesday, November 25, 1997.; MENLO PARK, Calif.--(BW HealthWire)--Nov. 25, 1997--SEQUUS Pharmaceuticals, Inc. (NASDAQ:SEQU) today announced the signing of an exclusive agreement with CritiCare Laboratories Pvt. Ltd. for the marketing, sales and distribution of AMPHOCIL in India , Bangladesh ,
(BW) (SUN-MICROSYSTEMS/AIDS)(SUNW) Sun Delivers World's Largest AIDS Memorial Over Internet; AIDS Memorial Quilt Brings Home Powerful Message for Worldwide AIDS Day: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, November 24, 1997.; PALO ALTO, Calif.--(BUSINESS WIRE)--Nov. 24, 1997--Sun Microsystems, Inc. is providing the technological backbone for the NAMES Project Foundation s massive undertaking. The world s largest community art project and AIDS memorial is available for viewing at http://www.aidsquilt.org. The names and images which make up t
(BW) (BIOCHEM-PHARMA)(BCHE) European CPMP Gives Positive Opinion on Combivir, the First Tablet to Combine Two Anti-HIV Drugs: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; LAVAL, QUEBEC--(BUSINESS WIRE)--Nov. 21, 1997--BioChem Pharma Inc. (NASDAQ: BCHE; Montreal Exchange, Toronto Stock Exchange: BCH) announced today that the European Union s Committee for Proprietary Medicinal Products (CPMP) this week recommended the approval of Combivir , the first tablet to combine tw
(BW) Playboy TV Produces "World AIDS Day" Special, "Doin' it Right": First TV Special on Heterosexual HIV/AIDS Prevention To Air on Playboy TV Dec. 1: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday November 20, 2:08 pm Eastern Time; BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Nov. 20, 1997--Continuing its support of AIDS awareness, Playboy TV will air Doin it Right, the first TV special on heterosexual HIV/AIDS prevention, on World AIDS Day, Dec. 1. In keeping with the day s global theme, the program will also air on Playboy TV networks in the
(BW) (HOME-ACCESS-HEALTH) ADVISORY/Free Home Access HIV Testing on World AIDS Day; Home Access Health Corporation to Donate Free HIV Home Tests: BUSINESS WIRE; November 20, 1997.; Business Editors, Health & Medical Writers ADVISORY...for Dec. 1 (Monday) (BUSINESS WIRE)--WHAT: In observance of World AIDS Day on December 1st, Home Access Health Corporation will offer free Home Access(R) Express(TM) HIV tests to individuals who want to get tested. (There is a $6.00 shipping and handling fee.)
(BW) National Hotline for Advice on Occupational Exposures to HIV and Other Blood Borne Diseases Opens at San Francisco General: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, November 17, 1997.; SAN FRANCISCO--(BUSINESS WIRE)--Nov. 17, 1997--Health care workers are often exposed through occupational accidents to HIV or hepatitis and other blood borne diseases. Studies have found that prompt treatment for exposures can help to reduce the number of persons who actually become infected from these accidents. No
(BW) (UCSF-STANFORD-HEALTH) ADVANCE/National Hotline for Advice on Occupational Exposures to HIV and Other Blood Borne Diseases Opens at San Francisco General: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 17 November 1997.; (ADVANCE) SAN FRANCISCO--(BUSINESS WIRE)--Nov. 17, 1997--Health care workers are often exposed through occupational accidents to HIV or hepatitis and other blood borne diseases. Studies have found that prompt treatment for exposures can help to reduce the number of persons who actually become infected from these accide
(BW) (SALIVA-DIAGNOSTICS)(SALV) Saliva Diagnostic Systems Enters Into Worldwide Private Label Agreement With Biochem Immunosystems Inc.: BUSINESS WIRE; November 17, 1997.; VANCOUVER, Wash.--(BUSINESS WIRE)--Nov. 17, 1997--Today, Saliva Diagnostic Systems, Inc. (SDS) (Nasdaq: SALV) announced it has signed an agreement with BioChem ImmunoSystems, Inc. the diagnostics subsidiary of BioChem Pharma Inc. (Nasdaq:BCHE)(TSE/ME: BCH), enhancing its ability to market and sell its products worldwid
(BW) (INFORMIX-SOFTWARE)(IFMX) Informix and The NAMES Project Foundation Marry Technology with Dynamic Art to Produce Worldwide Access to AIDS Memorial Quilt; Web Site Encompasses Over 40,000 Quilt Panels Managed And Searchable by Informix Database: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, November 24, 1997.; MENLO PARK, Calif--(BUSINESS WIRE)--Nov. 24, 1997-- Informix Software, Inc., (NASDAQ:IFMX) the leading provider of innovative database technology, and The NAMES Project Foundation, today announced the AIDS Memorial Quilt web site, a virtual display of over 70,000 names and over 43,000 images that make up the AIDS Memor
(BW) Home Access HIV Tests Available at Longs Drug Stores: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday November 13, 10:53 am Eastern Time; HOFFMAN ESTATES, Ill.--(BW HealthWire)--Nov. 13, 1997--Home Access Health Corporation, the telemedicine leader in providing fast and convenient at-home medical testing and consultation, has announced a retail distribution agreement with Longs Drug Stores, a privately held chain with stores located in California, Hawaii
(BW) (KAISER-PERMANENTE) Kaiser Sponsors Town Hall Meeting on HIV Care: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 13 November 1997.; OAKLAND, Calif.--(BW HealthWire)--Nov. 13, 1997--In a rapidly changing medical field -- the care of HIV patients -- Kaiser Permanente is striving to reach out to the community by sponsoring its second annual town hall meeting on HIV: HIV Care 2000. The program will highlight some of the changes that have taken place at
(BW) (HOOVER-INSTITUTION) Congress' Poltroonery Prevents Real FDA Reform: An Analysis by Henry I. Miller, M.D., Hoover Institution Senior Research Fellow: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 13 November 1997.; STANFORD, Calif.--(BW HealthWire)--Nov. 13, 1997--The following is an analysis by Henry I. Miller of the FDA reform bill passed by Congress on November 9. Henry I. Miller, M.D., is a Senior Research Fellow at Stanford University s Hoover Institution, and former senior FDA official (1979-94), whose research focuses on F
(BW) (SPECIALIZED-HEALTH)(SHPI) Specialized Health Products International Inc. Announces National Distribution Agreement with Alliance Medical: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 12 November 1997; BOUNTIFUL, Utah--(BW HealthWire)--Nov. 12, 1997--Specialized Health Products International Inc. (NASDAQ:SHPI) today announced its wholly-owned subsidiary, Specialized Health Products Inc. ( SHP ), has signed a national Distribution Agreement with Alliance Medical ( Alliance ) to market and sell SHP s ExtreSafe(R) lance
(BW) Mexico Approves HIV ShiloovTube for Early Detection of the HIV Virus that Causes AIDS; First Sales Expected in Early 1998: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday November 10, 10:00 am Eastern Time; REHOVOT, Israel--(BW HealthWire)--Nov. 10, 1997--Shiloov Medical Technologies Ltd. announced today that the Mexican Ministry of Health has approved the use of the HIV ShiloovTube(TM) as a blood pre-treatment device that improves the detection of HIV, the virus that causes AIDS infection. Shiloov plans to begin marketin
(BW) Merck Licenses Vical's "Naked" DNA Technology For Therapeutic Vaccines: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday November 4 4:21 PM EST; SAN DIEGO--(BUSINESS WIRE)--Nov. 4, 1997--Vical Inc. (Nasdaq:VICL) announced today the signing of an agreement granting Merck & Co. , Inc. (NYSE:MRK) certain rights to develop and market therapeutic vaccines against the human immunodeficiency virus (HIV) and the hepati
(BW) (STARBRIGHT-FOUNDATION) REMINDER/President Clinton and Vice President Gore Join Steven Spielberg and General Schwarzkopf in Live Demonstration of STARBRIGHT World, an Interactive Computer Network Linking Hospitalized Children Nationwide: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 30 October 1997.; (BUSINESS WIRE)--President and Vice President go online to talk face to face with kids in hospitals across the country and announce 1998 expansion of STARBRIGHT World *T WHO: President Clinton and Vice President Gore will join STARBRIGHT Chairman Steven Spielberg and STARBRIGHT Capital Campaign Chairman General H. Norm
(BW) (SHAMAN-PHARMACEUTICALS)(SHMN) Shaman Announces Positive Results and Continuation of Development of Provir for Treatment of AIDS Diarrhea and Status of Provir Acute Watery Diarrhea Studies: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 30 October 1997.; SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--Oct. 30, 1997--Shaman Pharmaceuticals, Inc. (NASDAQ:SHMN) announced today the results of a Phase II double-blind, randomized, placebo-controlled pilot study that examined Provir s ability to treat diarrhea in patients with AIDS. The study was a five-day, in-hospital trial t
(BW) (EPIMMUNE/CYTEL)(CYTL) Epimmune Publishes Studies Showing Vaccine Technology Identifies Disease-Specific Epitopes: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 30 October 1997.; SAN DIEGO--(BUSINESS WIRE)--Oct. 30, 1997--Epimmune Inc., a wholly owned subsidiary of Cytel Corp. (NASDAQ:CYTL), Thursday announced the publication of three papers in peer-reviewed scientific journals that demonstrate the ability of Epimmune s proprietary T-cell epitope selection technology to identify relevant diseas
(BW) Combination of Urine and Blood-Based Tests Results in More Sensitive HIV-1 Antibody Detection; People Exhibiting Antibodies in One Body Fluid but Not the Other Provide New Clues in the Fight Against HIV/AIDS: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday October 28 5:02 PM EST; BERKELEY, Calif.--(BW HealthWire)--Oct. 28, 1997--New research shows that a combination of urine and blood-based tests can detect antibodies to the human immunodeficiency virus, type 1 (HIV-1) with greater sensitivity than can be achieved by either test alone. Results of clinical trials reported by researchers from Cal
(BW) (AMERICAN-DIVERSIFIED)(ADGI) ADGI Ships HIV Test Kits to Mali: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; HICKORY, N.C.--(BW HealthWire)--Oct. 28, 1997--American Diversified Group (OTC BB:ADGI) Monday announced that it has arranged for the initial shipment of HIV Test Kits to the National Blood Bank of Mali pursuant to an order announced on Oct. 14, 1997. ADGI has confirmed that the 2,500 HIV Test Kits, part of an order fo
(BW) (VIMRX-PHARMACEUTICALS)(VMRX) VIMRX Begins Phase II Clinical Studies of VIMRxyn-R -synthetic hypericin- as Topical Phototherapy For Skin Diseases; Studies to be conducted at the University of Pennsylvania: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 23 October 1997.; WILMINGTON, De.--(BW HealthWire)--Oct. 23, 1997-- VIMRX Pharmaceuticals Inc. (NASDAQ: VMRX) today announced that it has initiated a Phase II clinical trial to evaluate VIMRxyn(R) (synthetic hypericin) as a topically applied, light-activated therapy for specific skin diseases including psoriasis, cutaneous T-cell
(BW) (CALYPTE-BIOMEDICAL) Calypte Biomedical Offering Raises $10 Million; First Urine-Based Test System for HIV-1: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 22 October 1997; ALAMEDA, Calif.--(BW HealthWire)--Oct. 22, 1997--Calypte Biomedical Corp. today announced the completion of a private placement of common stock which raised over $10 million. Pacific Growth Equities acted as sole placement agent on the offering. Following this transaction, the company has 13.1 million weighted average
(BW) (STANFORD-MEDICAL-CENTER) Stanford Offers Complete HIV Testing for Antiviral Drug Resistance: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 21 October 1997.; STANFORD, Calif.--(BW HealthWire)--Oct. 21, 1997--HIV-positive individuals can get a new test at Stanford University Medical Center to determine whether the strain of virus in their blood is resistant to one or more antiviral drugs. The test, called HIV antiviral resistance testing by genotyping, involves genetic analy
(BW) (PROCEPT)(PRCT) Procept Completes Phase I Clinical Program for PRO 2000 Gel; Antiviral gel well tolerated in Antwerp and London clinical trials: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 21 October 1997.; CAMBRIDGE, Mass.--(BW HealthWire)--Oct. 21, 1997-- Procept Inc. (NASDAQ:PRCT) today announced the completion of its second Phase I safety trial in London, United Kingdom with the company s lead drug candidate, PRO 2000 Gel. The product is designed to be used for the prevention of human immunodeficiency virus type 1 (HI
(BW) (PROCEPT)(PRCT) Procept Receives Second Patent for PRO 2000: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; CAMBRIDGE, Mass.--(BW HealthWire)--Oct. 15, 1997--Procept Inc. (Nasdaq:PRCT) announced today that it has been issued Patent 5,677,343 covering its PRO 2000 gel, a topical microbicide it is developing as a chemical barrier to prevent HIV infection. This is the second patent the company has been issued relating to the pr
(BW) National Blood Bank-Mali Orders HIV Test Kits: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday October 14 12:36 PM EDT; HICKORY, N.C.--(BW HealthWire)--Oct. 14, 1997--American Diversified Group (OTC BB:ADGI) Tuesday announced that it has received an initial order for approximately 4,500 HIV test kits from its representative, PERGUE S.A.R.L., for the National Blood Bank of Mali . This order is being shipped in October 1997, and is part o
(BW) (POOLED-BLOOD-TESTING) Pooled Testing of Blood Donors Saves Lives, Saves Money: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 13 October 1997.; PALO ALTO, Calif.--(BW HealthWire)--Oct. 13, 1997--The blood supply has been a chief pathway for the spread of AIDS. To protect it, the American Red Cross long ago started testing the blood of all volunteer donors. But in poor regions of the world, such vigilant screening is out of the question. In parts of Africa, for
(BW) Innovative Test Tells Doctors When HIV Becomes Resistant to Most Commonly Used AIDS Drugs: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday October 22 7:11 PM EDT; (BUSINESS WIRE)-- The LiPA HIV-1 RT test can predict when a particular drug will stop working and enable doctors to switch patients to another treatment. It will also allow them to put newly-diagnosed patients on the most suitable mediation from the start. Watch streaming video which discusses how the LiPA HIV-1 RT tes
(BW) (IBC) Potential HIV Infection: HIV Turned Against Itself: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 8 October 1997.; SOUTHBORO, Mass.--(BW HealthWire)--Oct. 8, 1997--A recent September issue of Cell reports exciting news of a novel anti-HIV-1 strategy involving sophisticatedly engineered viruses that seek and destroy human HIV-1 infected cells only, then move on to seek out and destroy other HIV-1 infected cells. (Mebatsion et al., 1
(BW) (UCSF/MARIJUANA/AIDS) Study of Effects of Marijuana on HIV-Infected Patients Approved by NIH: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 8 October 1997.; SAN FRANCISCO--(BW HealthWire)--Oct. 8, 1997--After several attempts to secure approval, funding, and the government-supplied marijuana required for a study of the effects of marijuana on HIV-infected patients, a group of UCSF physician-scientists and the Community Consortium has been successful in presenting a clinica
(BW) (KAISER PERMANENTE/HIV) Kaiser Permanente Offers Unique Classes for People with HIV: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 8 October 1997.; OAKLAND, Calif.--(BW HealthWire)--Oct. 8, 1997--Although new and more promising drugs are helping to make AIDS into a chronic, and not always fatal disease, living with HIV is still quite difficult. That s why a new workshop at Kaiser Permanente aims to help people with HIV deal with their illness more effectively. No
(BW) Selenium Deficiency Again Linked to Poor Health; High-Potency Organic Selenium Proven to be Safest Form of Nutritional Supplement: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday October 2 8:04 AM EDT; COSTA MESA, Calif.--(BW HealthWire)--Oct. 2, 1997--Adding to mounting evidence of selenium s health benefits, this week s Journal of Acquired Immune Deficiency Syndrome reported that HIV-infected men and women with selenium deficiency were 19.9 times more likely to die of AIDS than those with adequate selenium levels.
(BW) Liposomal Antifungal Agent As Effective and Safer Than Standard Treatment: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday October 1 10:16 AM EDT; TORONTO--(BW HealthWire)--Oct. 1, 1997-- AmBisome(R) Superior to Conventional Amphotericin B in Reducing Proven Treatment-Emergent Fungal Infections, Nephrotoxicity and Infusion-Related Toxicity A new liposomal antifungal agent is as effective and safer than conventional therapy for the treatment of presumed fungal inf
(BW) (UCSF/PROTEASE-INHIBITORS) ADVANCE/Protease Inhibitors Failed Half the Time in UC San Francisco Study: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 29 September 1997.; ADVANCE...for release 9 a.m. PDT Sept. 29 Note: To coincide with presentation at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (ADVANCE) TORONTO--(BW HealthWire)--Sept. 29, 1997--In a retrospective study of 136 HIV-infected patients who took potent protease inhibitor therapy, more th
(BW) SENTRY-ANTIMICROBIAL-SURV) Worldwide Antibiotic Resistance Patterns Show Alarming Upward Trends: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 29 September 1997; TORONTO--(BW HealthWire)--Sept. 29, 1997--SENTRY ANTIMICROBIAL SURVEILLANCE data confirm need for new antibiotics and better-focused local infection control practices. Results from the first seven months of SENTRY ANTIMICROBIAL SURVEILLANCE(1) were reported today during the 37th Interscience Conference on Antimicrobial
(BW) (XOMA) XOMA's BPI-Derived Products Show Synergy with AntiBiotics Against Multi-Drug Resistant Bacteria and with Antifungals Against Pathogenic Fungal Organisms; 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), American Society for Microbiology: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 29 September 1997.; BERKELEY, Calif.--(BW HealthWire)--Sept. 29, 1997--New research by XOMA Corporation (NASDAQ:XOMA) further demonstrates the breadth of the company s BPI (bactericidal permeability-increasing protein) anti-infective development platform. Company scientists have demonstrated that formulations of the BPI-derived compound r
(BW) (SALIVA-DIAGNOSTIC)(SALV) SE Asia Studies Show Good Results for Saliva Diagnostic Systems' Rapid HIV Test; Vietnam and Malaysia studies compare Hema-Strip HIV to other widely-used HIV tests New distribution partners in South America: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; VANCOUVER, Wash.--(BUSINESS WIRE)--Sept. 29, 1997-- Studies recently completed by independent investigators in Malaysia and Vietnam using Hema-Strip HIV, a rapid whole blood test developed by Saliva Diagnostic Systems, Inc. (Nasdaq: SALV), indicate the device is equivalent in sensitivity and specificity to other, widel
(BW) BioChem Pharma Announces U.S. FDA Clearance of Combivir, the First Tablet to Combine Two Anti-HIV Drugs, Including 3TC: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday September 29 9:40 AM EDT; LAVAL, Quebec--(BUSINESS WIRE)--Sept. 29, 1997--BIOCHEM PHARMA(ME, TSE:BCH., NASDAQ:BCHE.) BioChem Pharma Inc. announced today that its licensee Glaxo Wellcome Inc. has received clearance from the US Food and Drug Administration ( FDA ) to market C
(BW) (HOME-ACCESS-HEALTH-CORP) Media Statement Issued by Home Access Health: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 26 September 1997.; CHICAGO--(BW HealthWire)--Sept. 27, 1997--Home Access Health Corp. supports the U.S. Food and Drug Administration s ( FDA ) prompt action in warning the public regarding the illegitimate sale of the Lei-Home Access HIV test on the Internet. Home Access Health is the only company currently selling an FDA-approved HIV at
(BW) (CALYPTE-BIOMEDICAL)(CALY) U.S. FDA Issues "Review Complete" Notice for Urine HIV-1 Confirmation Test: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 18 September 1997.; ALAMEDA, Calif.--(BW HealthWire)--Sept. 18, 1997--Calypte Biomedical Corp. (NASDAQ:CALY) announced today that Cambridge Biotech Corp. has received official notice from the FDA that the agency has completed its review of the Cambridge Biotech/bioMerieux Vitek application supplement for its Human Immunodeficiency Virus T
(BW) (VICAL/MERCK)(VICL) Merck Licenses Vical's "Naked" DNA Technology to Deliver Certain Growth Factors: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 15 September 1997.; SAN DIEGO--(BW HealthWire)--Sept. 15, 1997--Vical Inc. (Nasdaq:VICL) announced today the signing of an agreement granting Merck & Co. , Inc. (NYSE:MRK) certain rights to use Vical s naked DNA technology to deliver certain growth factors. The agreement resulted in an initial payment to Vical of $2 million and has a
(BW) (HOME-ACCESS/HIV-TEST) New Home Access HIV Test Available on California College Campuses; Students Can Now Order Direct 24 Hours a Day, 7 Days a Week by Telephone: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 12 September 1997; HOFFMAN ESTATES, Ill.--(BW HealthWire)--Sept. 12, 1997-- Students on California college campuses now have instant toll-free access to purchase either Home Access Express(R) (results in 3 days) or Home Access(R) (results in about a week), both products allow people to anonymously test for HIV within the privacy of their
(BW) (AMERICAN-DIVERSIFIED-GRP)(ADGI) National Blood Bank-Mali Requests ADGI Ship HIV Test Kits: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 10 September 1997.; HICKORY, N.C.--(BUSINESS WIRE)--Sept. 10, 1997--American Diversified Group Inc. (OTC BB:ADGI) Wednesday announced that the National Blood Bank of Mali has requested that ADGI ship for approval and sale HIV Test Kits, which will be shipped to the National Blood Bank within 10 days. The HIV Test Kits are part of the rec
(BW) Breaking New Ground in Santa Monica For People Living With HIV & AIDS: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday September 9 5:39 PM EDT; SANTA MONICA, Calif.--(BUSINESS WIRE)--Sept. 9, 1997-- Rick Weiss New Hope Apartments to Provide the City s First-Ever Long-Term Assisted Housing For Individuals & Families in Need Nonprofit AIDS service organization Project New Hope will hold a groundbreaking ceremony for the Rick Weiss New Hope Apartments on Frid
(BW) (UCSF/TUBERCULOSIS) ADVANCE/State Tuberculosis Program for Noncompliant Patients Needs Improvement, According to UCSF Study: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 9 September 1997.; (ADVANCE) SAN FRANCISCO--(BW HealthWire)--Sept. 9, 1997-- Tuberculosis (TB) control policies should provide reasonable access to housing, psychiatric and substance abuse care for patients who persistently do not adhere to their TB treatment, according to an analysis of California s TB control policy published in this w
(BW) (CORTISOL-STUDY) Study Finds Hidden, Major Destructive Role of High Cortisol Hormone in AIDS, Aging, Other Diseases: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 9 September 1997.; LAS VEGAS--(BW HealthWire)--Sept. 9, 1997-- Correcting Misleading Laboratory Reporting Could Lead to Use of New Diagnostics, Anti-Cortisol Treatments A study published in the September 1997 issue of Psychoneuroendocrinology, Oxford, U.K., reveals information about the role of cortisol in health and disease. Cortisol (
(BW) (STANFORD-MEDICAL-CENTER) Study Casts Doubt on Effectiveness of TB Vaccine: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; STANFORD, Calif.--(BW HealthWire)--Sept. 11, 1997--The tuberculosis vaccine known as BCG has been given to more people worldwide than any other vaccine, yet its effectiveness remains controversial. A new analysis by researchers at Stanford School of Medicine suggests that the bacterial strains used in current BCG vacci
(BW) (CHIRON)(CHIR) Chiron Announces Dr. Liu to Head U.S. Vaccines Research; Addition of Preeminent Vaccine Specialist Expands Chiron's Scientific Expertise: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 8 September 1997.; EMERYVILLE, Calif.--(BW HealthWire)--Sept. 8, 1997--Chiron Corporation (NASDAQ:CHIR) announced today the appointment of Margaret A. Liu, M.D., as vice president of vaccines research. Dr. Liu will be responsible for all Chiron s U.S. vaccine research including work on DNA-based vaccines. She will report directly to Lewi
(BW) (MAXXON)(MXON) Maxxon Inc. Hypodermic Safety Syringe Designer Announces Prototype Ready for Testing; Design Should Help Reduce Transmission of HIV and AIDS Virus: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 5 September 1997.; TULSA, Okla.--(BUSINESS WIRE)--Sept. 5, 1997--Maxxon Inc. (OTC BB: MXON) William Robinson, vice president, announced today the delivery of the engineered prototype of the Maxxon Safety Syringe(TM). Texas Applied Biotechnology Services president, Ms. Joyce Heinrich, informed Robinson that the prototype syringe would be
(BW) (HOME-ACCESS-HEALTH/CVS)(CVS) CVS Stores To Sell Home Access HIV Tests: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 5 September 1997.; HOFFMAN ESTATES, Ill.--(BW HealthWire)--Sept. 5, 1997--Home Access Health Corporation, the telemedicine leader in providing fast and convenient at-home medical testing and consultation, has announced a retail distribution agreement with CVS Corporation (NYSE:CVS), the nation s largest chain drug store company. By Octob
(BW) (HOME-ACCESS-HEALTH) Home Access Health to Offer Free HIV At-Home Replacement Test Kit to Purchasers of Confide: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 29 August 1997; HOFFMAN ESTATES, Ill.--(BW HealthWire)--Aug. 29, 1997--Home Access Health Corp., maker of Home Access Express(R) HIV test system, will offer a free HIV test kit to consumers who have purchased Confide(R) and are unable to obtain their test result as a result of Johnson & Johnson s June 26, 1997 announcement that it
(BW) World Health Organization Collaboration Centre on AIDS Reports Pace HIV Test "Excellent" and Suitable for Global Distribution: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday August 28 12:15 PM EDT; TORONTO--(BUSINESS WIRE)--Aug. 28, 1997--PACE (CANADIAN DEALING NETWORK PACL.) The Pace Corporation today announced that the World Health Organization s Collaborating Centre on AIDS, the Program for Appropriate Technology in Health (PATH), has completed tests of the Company s rapid HIV-LOGIC(TM) test kit. The PATH repo
(BW) (APACHE-MEDICAL-SYSTEMS)(AMSI) Health Council of South Florida Contracts with APACHE for HIV/AIDS Disease Management: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 26 August 1997.; MCLEAN, Va.--(BUSINESS WIRE)--Aug. 26, 1997--APACHE Medical Systems, Inc. (NASDAQ:AMSI) today announced an agreement with the Health Council of South Florida to provide services related to the Medicaid Outcomes Health Management Initiative ( the HMI Project ) for HIV/AIDS patients. The HMI Project is designed to improv
(BW) (UCSF/HIV-RISK) Risky Sex, STDs, and Condom and Drug Use Affect HIV Risk for Straight Couples, Says UCSF Researcher: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 25 August 1977.; SAN FRANCISCO--(BW HealthWire)--Aug. 25, 1997--In the nation s largest and longest study of heterosexual HIV transmission, UC San Francisco researchers found that the practice of anal sex, lack of condom use, injection drug use and the presence of a sexually transmitted disease (STD) are the strongest predictors of inf
(BW) (NATL-AIDS-FUND/MET-LIFE) FEATURE/Youth Become Role Models in the Fight Against AIDS: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 21 August 1997.; WASHINGTON--(BUSINESS WIRE FEATURES)--Aug. 21, 1997--For some teenagers, the appeal of helping others is more enticing than watching TV, surfing the Net or playing with friends. A dedicated group of 22 such young people from across the country have become role models for both adults and adolescents in the fight against
(BW) Bonito Acquires Exclusive License for HIV Detection Kit: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday August 27 12:59 AM EDT; STAUFENBERG, Germany--(BW HealthWire)--Aug. 26, 1997--Bonito Industries Inc. (OTC BB:BNTO) Tuesday announced that it has entered into an agreement with Laboserv s.r.l. of Germany for the acquisition of the exclusive distribution rights for the sale of a new HIV home detection kit. Preliminary testing of the HIV detecti
(BW) (SALIVA-DIAGNOSTIC)(SALV) Rapid Saliva HIV Test to be Marketed in United Kingdom: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 20 August 1997.; VANCOUVER, Wash.--(BUSINESS WIRE)--Aug. 20, 1997-- - Saliva Diagnostic Systems to begin aggressive sales campaign for Saliva-Strip(TM) HIV - A rapid test that uses saliva to detect HIV antibodies will be marketed for professional use in the United Kingdom , medical diagnostics maker Saliva Diagnostic Systems, Inc. (Nas
(BW) Metropolitan Water District Recommits To Campaign Against Cryptosporidium: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 19 August 1997.; LOS ANGELES, Calif.--(BUSINESS WIRE)--Aug. 19, 1997--Recommitting itself to research and public education about a potentially deadly organism, Metropolitan Water District s board of directors today authorized $442,000 for a third year of its Cryptosporidium Action Plan. Around-the-clock monitoring of our filtration pla
(BW) (BEHRING-DIAGNOSTICS) Behring Diagnostics and Boehringer Mannheim License HIV-O to Abbott Laboratories: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 19 August 1997.; FRANKFURT, Germany--(BW HealthWire)--August 19, 1997--Behring Diagnostics, a member of the Hoechst Group, and Boehringer Mannheim today announced that they have signed a non-exclusive worldwide licensing agreement with Abbott Laboratories for patents and patent applications covering human immunodeficiency virus 1 group
(BW) (CELL-ROBOTICS)(CRII) FDA Clears Cell Robotics' New Laser Device for Blood Sampling in Glucose Testing: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 19 August 1997.; ALBUQUERQUE, N.M.--(BW HealthWire)--Aug. 19, 1997--Cell Robotics International Inc. (OTC: CRII) announced that it has received clearance from the FDA to market its Lasette(TM) laser finger perforator. The Lasette is a small, hand-held battery-operated laser device that produces a small hole in the finger with a single
(BW) GalaGen Initiates Phase II Clinical Trial with Diffistat-G for Antibiotic-Associated Diarrhea: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; ARDEN HILLS, Minn.--(BW HealthWire)--August 14, 1997--GalaGen Inc. (Nasdaq: GGEN) today announced that it has initiated a multi-center Phase II clinical trial of Diffistat-G(TM), the Company s polyclonal antibody drug for the treatment of antibiotic-associated diarrhea, a life-threatening illness caused by the pathogen
(BW) Ft. Laud. Company Offers New Income Opportunity in the Viatical Industry: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 13 August 1997.; FORT LAUDERDALE, Fla.--(BW HealthWire)--Aug. 13, 1997--Ft. Lauderdale-based Page & Associates recently began offering the first free Viatical Settlement Representative certification course in the United States . This course was designed to help educate people wanting to become representatives in the ever growing vi
(BW) (HOME-ACCESS-HEALTH) Home Access Health to Offer Free HIV At-Home Replacement Test Kit to Purchasers of Confide: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 13 August 1997, 10:02 Pacific; HOFFMAN ESTATES, Ill.--(BW HealthWire)--Aug. 13, 1997--Home Access Health Corp., maker of Home Access Express(R) HIV test system, will offer a free HIV test kit to consumers who have purchased Confide(R) and are unable to obtain their test result as a result of Johnson & Johnson s June 26, 1997 announcement that it
(BW) Changes in AIDs Epidemic Reflected at Clinic: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday August 12, 1997 4:50 PM EDT; STANFORD, Calif.--(BUSINESS WIRE)--Aug. 12, 1997--Three years ago, the Positive Care Clinic opened its doors to HIV patients in a former general medicine ward at Stanford University Hospital. Since then, the epidemic has entered a new era, with many patients now experiencing AIDS as a manageable, chronic disease. The c
(BW) (HOME-ACCESS-HEALTH) Home Access Health Urges Consumer Caution Via Internet: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 7 August 1997.; HOFFMAN ESTATES, Ill.--(BW HealthWire)--Aug. 7, 1997--Home health care consumers searching the Internet should be aware of the marketing activities of unapproved and illegal HIV home test kits according to Home Access Health Corporation, the leader in telemedicine, providing fast and convenient at-home medical testing
(BW) (NEXSTAR-PHARMACEUTICALS)(NXTR) South Korea Approves AmBisome as a First Line Therapy: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 7 August 1997.; BOULDER, Colo.--(BW HealthWire)--Aug. 6, 1997--NeXstar Pharmaceuticals, Inc. (NASDAQ:NXTR) today announced that the Korean Ministry of Health has granted marketing approval for AmBisome, as a first line, or primary therapy, for systemic fungal infections, including Candidiasis, Histoplasmosis, Cryptococcus and
(BW) Laboratory Corporation of America Becomes First Commercial Laboratory To Offer HIV Genotyping Services Using Affymetrix: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; BURLINGTON, N.C.--(BUSINESS WIRE)--August 5, 1997--Laboratory Corporation of America(TM) Holdings (LabCorp(TM))(NYSE: LH) today announced that it is the first commercial reference laboratory to offer HIV genotyping using GeneChip(R) DNA probe arrays and polymerase chain reaction (PCR) based assays. GeneChip Probe array
(BW) (WA-DEPT-OF-HEALTH) Hepatitis B Vaccinations Up 44 Percent Since March `95: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 5 August 1997; OLYMPIA, Wash.--(BUSINESS WIRE)--Aug. 5, 1997--More Washington children now are protected against hepatitis B than ever before according to the state Department of Health. A national immunization survey released last week by the Centers for Disease Control and Prevention indicates that the hepatitis B immunization rate
(BW) Tuskegee 2? Controversial AIDS Testing - Or Torture? - in Africa: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 4 August 1997.; NEW YORK--(BUSINESS WIRE)--August 4, 1997--In AIDS-ravaged Africa, a controversial drug study is leaving pregnant women at risk and stirring outrage. VIBE contributor Harry Allen investigates the issue in the Fourth Anniversary special September Juice issue, on sale August 5. As President Clinton publicly apologizes to
(BW) AmBisome Cleared for Marketing in the U.S.: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday August 12, 1997 - 12:02 PM EDT; DEERFIELD, Ill. and BOULDER, Colo.--(BW HealthWire)-- Aug. 12, 1997-- First Liposomal Amphotericin B Indicated for Empirical Therapy for Presumed Fungal Infections in Immunocompromised Patients Fujisawa USA , Inc. and NeXstar Pharmaceuticals, Inc. (NASDAQ:NXTR) announced today that the U.S. Food and Drug Administration
(BW) (PURE-H20-BIO-TECH)(PHBT) Pure H20 Bio-Technologies Inc.'s 100% "Kill" of Cryptosporidium With Purification/Disinfection Systems Saves Lives: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 31 July 1997; BOYNTON BEACH, Fla.--(BW HealthWire)--July 31, 1997--Pure H20 Bio-Technologies (PHBT) reported that its water disinfection/purification systems killed Cryptosporidium, a deadly water-borne disease that has already killed more than 400 Americans and has caused 370,000 people to become ill to date. No other water purific
(BW) (SEQUUS-PHARMACEUTICALS)(SEQU) Sequus Pharmaceuticals Receives Market Clearance for CAELYX in Australia and New Zealand: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 30 July 1997.; MENLO PARK, Calif.--(BUSINESS WIRE)--July 30, 1997--SEQUUS Pharmaceuticals, Inc. (Nasdaq: SEQU) announced that the regulatory authorities in Australia and New Zealand have granted marketing clearance for its proprietary anticancer drug, DOXIL , in the treatment of Kaposi
(BW) (MOTHERS'-VOICES) Mothers' Voices and Shareholders Unite in Demanding that Glaxo Wellcome Take Action for People in Need of New Drug: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 28 July 1997.; NEW YORK--(BUSINESS WIRE)--July 28, 1997-- NY State Commonwealth Retirement Fund, together with Mothers Voices, other prominent AIDS organizations, and NYC Council call for the availability of 1592, a powerful new drug in the treatment of AIDS State Comptroller H. Carl McCall, the sole trustee of the New York State Com
(BW) (HOME-ACCESS/HIV-TEST) Home Access HIV-1 Test System Now Available at Thrifty PayLess: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 28 July 1997.; HOFFMAN ESTATES, Ill.--(BW HealthWire)--July 28, 1997--Home Access Health Corporation, the telemedicine leader in providing fast and convenient at-home medical testing and consultation, has announced a retail distribution agreement with Thrifty PayLess drug stores, a subsidiary of the Rite Aid Corporation (NYSE:RAD). P
(BW) (SF-AIDS-FOUNDATION) San Francisco AIDS Foundation Conducts Qualitative Focus Groups to Better Understand Changing Dynamics of AIDS Epidemic, Effect of New Treatments, and Changing Client Need; Results Will Inform S.F. AIDS Foundation Program and Service Delivery and Design: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 21 July 1997.; SAN FRANCISCO--(BW HealthWire)--July 21, 1997--Analysis of treatment and services data from 11 recent qualitative focus groups of San Francisco AIDS Foundation (SFAF) clients indicated three main trends: clients are generally gaining access to new treatments and have a high level of access to primary medical care, howe
(BW) FEATURE/Largest Compilation of HIV/AIDS Resources in the United States Now Available: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 21 July 1997.; LONGMONT, Colo.--(BUSINESS WIRE FEATURES)--July 21, 1997-- Guides for Living announced today the release of the third edition of HIV /AIDS Resources. This award-winning directory, touting a staggering 29,500 listings, is the most comprehensive nationwide compilation of HIV and AIDS service providers available. The dire
(BW) (UCSF/BEST-HOSPITALS) UCSF Medical Center Named One of "America's Best Hospitals"; San Francisco General Hospital Ranked Best in AIDS Care: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 18 July 1997.; SAN FRANCISCO--(BW HealthWire)--July 18, 1997--The UC San Francisco Medical Center ranks among the country s 10 best hospitals, according to a new survey conducted by U.S. News & World Report. The UCSF-affiliated San Francisco General Hospital ranks as the best center for AIDS care. Results of the survey of America
(BW) (HOME-ACCESS-HEALTH) Home HIV Test Kit Sales Driven by Retail Location; Consumers Look for Product in Front of the Counter: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 17 July 1997.; HOFFMAN ESTATES, Ill.--(BW HealthWire)--July 17, 1997--People are more likely to purchase a home access HIV test kit if the kits are placed on store shelves instead of behind a pharmacy counter, according to the results of a survey released today by Home Access Health Corporation, makers of the Home Access(R) HIV home
(BW) IDEC Pharmaceuticals Receives Notices of Allowance for Additional Patent Protection Covering Rituxan and Provax: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 16 July 1997.; SAN DIEGO, California--(BW HealthWire)--July 16, 1997--IDEC Pharmaceuticals (Nasdaq:IDPH) today announced the receipt of notices of allowance for three United States patents. The first allowed patent covers the company s IDEC-C2B8 (rituximab) antibody, now known as RITUXAN(TM), which is the subject of Biological Licens
(BW) FDA Antiviral Drug Committee Finds AmBisome Safe and Effective for Treatment of FUO: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 16 July 1997.; SILVER SPRING, Md.--(BW HealthWire)--July 16, 1997--NeXstar Pharmaceuticals, Inc. (NASDAQ:NXTR) and Fujisawa USA , Inc. announced that the U.S. Food and Drug Administration ( FDA ) Antiviral Drug Products Advisory Committee voted unanimously today that AmBisome(R) is safe and effective as empirical therapy for presumed
(BW) (KOSAN-BIOSCIENCES) SBIR to Pursue Antifungal Analog Library: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 16 July 1997.; BURLINGAME, Calif.--(BW HealthWire)--July 16, 1997--KOSAN Biosciences Inc., a biotechnology company based in Burlingame, announced today that it has received a Phase I Small Business Innovative Research (SBIR) grant from the National Institute of Allergy & Infectious Diseases (NIAID) to pursue research in Combinato
(BW) (HIV-THERAPY-AUDIT) New HIV Therapy Audit: The Only Projectable Database of Patients Seeking Treatment: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 16 July 1997; NEWTOWN, Pa.--(BW HealthWire)--July 16, 1997--Scott-Levin, a leading provider of consulting services to the pharmaceutical industry, today introduced the HIV Therapy Audit, the first product of its kind and the only projectable database of patients seeking treatment due to their HIV status. While the US Centers for Dis
(BW) (CHIRON)(CHIR) New England Journal of Medicine Study Confirms Vitrasert Implant More Effective Than IV Therapy for the Treatment of CMV Retinitis; New Treatment Strategy for People With AIDS Who Have Sight-Threatening Opportunistic Infections: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 14 July 1997.; CLAREMONT, Calif.--(BW HealthWire)--July 14, 1997--New data reported in the New England Journal of Medicine indicates that sustained-release ganciclovir (Cytovene; Roche Laboratories ) intraocular implant ( Vitrasert ; Chiron Vision) significantly delays the onset of cytomegalovirus
(BW) (CHIRON/FIRST-PROLEUKIN)(CHIR) REMINDER/Chiron Announces First Proleukin (IL-2) International Congress: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 10 July 1997.; REMINDER...for Thursday 7/10-Sunday 7/13 --(BW HealthWire)-- IL-2 is a human cytokine that has been found to stimulate the immune system and provide therapeutic benefit in patients with certain cancers and HIV. Oncologists are convening in San Francisco for the First Proleukin International Congress to present research
(BW) UC San Francisco Researchers Receive $4 Million NIH Grant to Study Acute Infection and Early HIV Disease: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday July 8 1:51 PM EDT; SAN FRANCISCO--(BW HealthWire)--July 8, 1997--Researchers at the University of California San Francisco have received funding from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, for a period of four years to focus on new and innovative ways to study how inf
(BW) CDC Extends Cooperative Agreement With Apache for Longitudinal HIV/AIDS Outpatient Research Study: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday July 8 4:01 PM; McLEAN, Va.--(BUSINESS WIRE)--July 8, 1997--APACHE Medical Systems, Inc. (NASDAQ:AMSI) today announced that the Centers for Disease Control and Prevention (CDC) has extended their Cooperative Agreement with APACHE s Health Research Network Division (HRN) through 2001. HRN has been performing longitudinal data collectio
(BW) American Pharmaceutical Partners and Glaxo Wellcome Announce Manufacturing and Supply Agreement for Acyclovir IV: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 8 July 1997; SANTA MONICA, Calif.--(BW HealthWire)--July 8, 1997--American Pharmaceutical Partners and Glaxo Wellcome Inc. announced an agreement whereby Glaxo Wellcome will manufacture and supply American Pharmaceutical Partners with 500 mg and 1000 mg formulations of lyophilized acyclovir.
(BW) Homeless AIDS Patients Should Have Access to Protease Drugs, UCSF Researchers Urge: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 2 July 1997; SAN FRANCISCO--(BW HealthWire)--July 1, 1997--The HIV -infected urban poor should be given access to protease inhibitors , say a group of UC San Francisco researchers specializing in studies of the homeless and marginally housed. Many homeless can adhere to the complex treatment regimens required and not to make them a
(BW) (WASH-DEPT-OF-HEALTH) Aberdeen, Cosmopolis and Wishkah River residents to boil water after heavy rain: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 1 July 1997.; OLYMPIA, Wash.--(BUSINESS WIRE)--July 1, 1997--Until a water filtration system is constructed, homes and businesses connected to the Aberdeen water supply will be advised to boil drinking water when storms or other factors threaten the city s drinking water supply, health officials announced at a meeting last night.
(BW) FDA Advisory Committee Recommends Clearance for Marketing of First U.S. Monoclonal Antibody for Cancer Treatment: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; SAN DIEGO and SOUTH SAN FRANCISCO--(BW HealthWire)--July 25, 1997-- IDEC Pharmaceuticals Corporation (NASDAQ:IDPH) and Genentech , Inc. (NYSE:GNE) today announced that Rituxan(TM) (Rituximab), also known as IDEC-C2B8, a monoclonal antibody, was recommended unanimously for marketing clearance by the Biological Response
(BW) (BIOCHEM-PHARMA)(BCHXF) 3TC Pediatric Clinical Endpoint Study shows that 3TC in combination with Retrovir significantly reduces the risk of disease progression and improves survival in children: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 27 June 1997.; LAVAL, Quebec--(BUSINESS WIRE)--June 27, 1997--BioChem Pharma Inc. (NASDAQ: BCHXF; Montreal Exchange, Toronto Exchange: BCH) announced today that a large U.S. study of children with symptomatic HIV disease has been stopped because an analysis of the data revealed that patients treated with
(BW) Significant increase in HIV counseling and testing reported at state-funded test sites; California AIDS Prevention: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 27 June 1997; SACRAMENTO, Calif.--(BW HealthWire)--June 27, 1997--In conjunction with National HIV Testing Day, State Health Director S. Kimberly Belshe announced that HIV counseling and testing at state-funded test sites increased by 29 percent among Californians who are most at risk for contracting the virus, according to new trac
(BW) S.F. AIDS Foundation's Trilingual AIDS Hotline to expand statewide on July 1; Hours increased as state streamlines three: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 26 June 1997; SAN FRANCISCO--(BW HealthWire)--June 26, 1997--The San Francisco AIDS Foundation s English, Spanish and Filipino AIDS information and referral hotline will expand beyond Northern California to answer calls from the entire state starting July 1, providing all Californians with one consistent source of AIDS information .
(BW) (HOME-ACCESS-HEALTH) Home Access Health Corporation makes statement: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 26 June 1997; HOFFMAN ESTATES, Ill.--(BW HealthWire)--June 26, 1997--Home Access Health Corporation is issuing the following statement from president Richard A. Quattrocchi: Home Access HIV testing is an important testing alternative for people. We will continue to provide consumers fast, accurate and convenient home medical test
(BW) U.S. Centers for Disease Control and Prevention seeks nominations for awards competition to recognize outstanding HIV/AIDS programs in the workplace: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday June 26 11:39 AM EDT; ATLANTA--(BUSINESS WIRE)--June 26, 1997--The U.S. Centers for Disease Control and Prevention (CDC) announced today a new plan to recognize outstanding HIV/AIDS prevention programs in the workplace and is seeking nominations for the awards. CDC will bestow National Business and Labor Awards for Leadership on HIV/AIDS to
(BW) FEATURE/CDC Director pulls invitation to discuss controversial book on AIDS-linked vaccines: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 26 June 1997.; ROCKPORT, Mass.--(BUSINESS WIRE FEATURES)--June 26, 1997-- Centers for Disease Control and Prevention (CDC) Director David Satcher, challenged by scientists, black leaders, and citizen groups concerned about vaccination risks, declined to discuss AIDS as a possible outcome of contaminated vaccines with the author of a
(BW) (CYTODYN) Patent awarded on hundreds of new immune antibody therapies for HIV/AIDS; enhanced treatments would boost human immune system: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 25 June 1997.; LOS ANGELES--(BW HealthWire)--June 25, 1997--A patent on the use of 200-plus antibody therapies specifically to treat HIV/AIDS has been awarded to scientist Allen D. Allen, who heads CytoDyn, a research firm based in Los Angeles. The patent, to be published by the U.S. Patent and Trademark Office on July 29, 1997, will
(BW) (UCSF/AIDS-CONFERENCE) ADVANCE/International panel of AIDS experts publishes updated recommendations on antiretroviral treatment for HIV infection: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 24 June 1997; (ADVANCE) SAN FRANCISCO--(BW HealthWire)--June 24, 1997--In response to new information in the treatment of HIV disease, updated guidelines have been published by an international panel of AIDS experts to advise caregivers and patients as they deal with the ever-changing state-of-the-art in therapies for HIV disease.
(BW) (SF-AIDS-FOUNDATION) U.S. Conference of Mayors urges Secretray of Health and Human Serivces Shalala to end Federal Restriction on needle exchange: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; SAN FRANCISCO--(BUSINESS WIRE)--June 24, 1997--The U.S. Conference of Mayors (USCM), at its annual meeting today; approved a bipartisan resolution -- co-sponsored by Democratic Mayor Willie Brown of San Francisco and Republican Mayor Richard Riordan of Los Angeles -- urging U.S. Secretary of Health and Human Services D
(BW) ILEX to review FDA panel decision with development partner: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; SAN ANTONIO--(BUSINESS WIRE)--June 23, 1997--ILEX Oncology, Inc. (NASDAQ: ILXO) today announced that the U.S. Food and Drug Administration s ( FDA ) Oncologic Drugs Advisory Committee found that there was not substantial evidence that Zyrkamine(R) (mitoguazone dihydrochloride for injection) was effective as a second-li
(BW) (CMA/ASSISTED-SUICIDE) Guidelines released for physician- assisted suicide; Western Journal of Medicine examines pros and cons of "hastened death": BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 23 June 1997; SAN FRANCISCO--(BW HealthWire)--June 23, 1997--Does physician-assisted suicide end the suffering of people who are terminally ill? Or is it a slippery slope leading to unnecessary deaths of patients unable to pay for continued care, or who are considered too heavy a burden? The latest issue of the Western Journal of Me
(BW) (DEPT-OF-HEALTH) Medical commission suspends license of Seattle doctor: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 17 June 1997; OLYMPIA, Wash.--(BUSINESS WIRE)--June 17, 1997--The license of Seattle physician Dr. Timothy J. Smith (MD18800) will be indefinitely suspended July 1 by the state Medical Quality Assurance Commission. Beginning January 1, 1998, Smith will be allowed to practice administrative medicine, peer and chart review, teaching a
(BW) New hope for treating diabetes and AIDS; Discovery of new human steroid conjugates offers therapeutic promise: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 12 June 1997.; MINNEAPOLIS--(BW HealthWire)--June 12, 1997--AMUR Pharmaceuticals Inc. today announced the discovery of a new class of human steroid conjugates. Six new steroid conjugates have been identified, the first of which is DHEA-PC (Dehydroepiandosterone-phosphocoline). Company researchers have synthesized DHEA-PC and have con
(BW) (CA-MEDICAL-ASSOCIATION) A community creates standards for end-of-life health care; an innovative project, but will it lead to "cookie cutter" medicine?: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 12 June 1997.; SACRAMENTO, Calif.--(BW HealthWire)--June 12, 1997--The 10 retired teachers gathered in a small Sacramento meeting room faced a daunting task. Although they possessed no medical training, the teachers were being asked to decide what kind of treatment people with dire health conditions should receive: should an advanced
(BW) ImmuCell's joint venture signs U.K. distributor agreement to begin sales of Crypto-Scan water diagnostic test; Announces its inclusion in EPA draft method: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 11 June 1997.; PORTLAND, Maine--(BW HealthWire)--June 11, 1997-- ImmuCell Corporation (Nasdaq:ICCC; BSE:IMU) announced today that its joint venture with New Jersey-based Membrex, Inc. has achieved two significant milestones relating to its Crypto-Scan(TM) water diagnostic test: 1) it has entered into an exclusive distributor relation
(BW) Novopharm Biotech Files IND for Recombinant Pan-Carcinoma Specific Human Antibody Fragment, NOVOMAb-G2 scFv; Company Awarded U.S. Patent For Monopharm-C, A Human Antibody to Adenocarcinomas: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 11 June 1997; TORONTO--(BUSINESS WIRE)--June 11, 1997--(TSE, VSE: NVO.) Novopharm Biotech Inc. (TSE & VSE:NVO) announced today that the company has filed an Investigational New Drug (IND) application with the Canadian Health Protection Branch (HPB) for a Phase I study of NOVOMAb-G2, a recombinant pan-carcinoma specific human ant
(BW) (CALIF-MEDICAL-ASSOC) Bill to weaken malpractice insurance fails in Assembly; Legislation would have reduced health care services for state's poor: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 9 June 1997.; SACRAMENTO, Calif.--(BW HealthWire)--June 9, 1997--California Medical Association is pleased to announce that legislation seeking to undermine the landmark Medical Injury Compensation Reform Act (MICRA) of 1975 has been placed on the Inactive File in the California Assembly. The action ensures that the Assembly will no
(BW) Advanced Plant Pharmaceuticals announces the filing of additional patent applications: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 9 June 1997.; NEW YORK--(BUSINESS WIRE)--June 9, 1997--Advanced Plant Pharmaceuticals Inc., (OTC Bulletin Board: APPI) today announced that it has filed a total of 13 patents covering the use of ABAVCA/PERTHON, which is currently under development by the company for use in the treatment of AIDS related symptoms. The patents filed co
(BW) Faulding Receives FDA Approval for Acyclovir Tablets: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 6 June 1997.; ELIZABETH, N.J.--(BW HealthWire)--June 6, 1997--Faulding Inc. s wholly owned subsidiary, Purepac Pharmaceutical Co., has received approval from the Food and Drug Administration to market acyclovir tablets, it was announced today by Richard F. Moldin, president and chief executive officer of Faulding Inc.
(BW) Bio-Technology General wins court ruling on hepatitis-B vaccine: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 6 June 1997.; ISELIN, NJ--(BUSINESS WIRE)--June 6, 1997--Bio-Technology General Corp. (NASDAQ:BTGC) today announced that the District Court in Tel-Aviv yesterday dismissed the appeal filed by Biogen, Inc., of a decision by the Israeli Commissioner of Patents which granted BTG s Israeli subsidiary a compulsory license under Biogen s
(BW) (UCSF/AIDS/CMV-RETINITIS) AIDS patients may develop CMV retinitis following antiretroviral therapy, UCSF study finds: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 5 June 1997.; SAN FRANCISCO--(BW HealthWire)--June 5, 1997--AIDS patients who are given protease inhibitors to treat their HIV infection may develop cytomegalovirus ( CMV ) retinitis following the treatment, a University of California San Francisco study has found.
(BW) (NEXSTAR-PHARMACEUTICALS)(NXTR) FDA Advisory Committee to review AmBisome FUO indication: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 4 June 1997.; BOULDER, Colo.--(BW HealthWire)--June 4, 1997--NeXstar Pharmaceuticals Inc. (NASDAQ:NXTR) and Fujisawa USA Inc. announced today that the U.S. Food and Drug Administration ( FDA ) has scheduled an Antiviral Drug Advisory Committee Meeting for Wednesday, July 16 to review data supporting the New Drug Application (NDA) fo
(BW) (UCSF/AIDS/LYMPHOMA) ADVANCE/Multi-center study finds low doses of chemotherapy effective in treating AIDS-related lymphoma: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 4 June 1997.; (ADVANCE) SAN FRANCISCO--(BUSINESS WIRE)--June 4, 1997--AIDS patients who suffer from non-Hodgkin s lymphoma (NHL), a fast-growing cancer of the lymph system, can be as effectively treated with low doses of chemotherapy as the standard high doses, a multi-center study led by researchers at UC San Francisco has found.
(BW) Procept completes Phase I safety trial of PRO 2000 gel; Antwerp trial finds antiviral gel well tolerated: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 2 June 1997.; CAMBRIDGE, Mass.--(BW HealthWire)--June 2, 1997--Procept, Inc. (Nasdaq:PRCT) today announced the completion of its Phase I safety trial in Antwerp, Belgium with the Company s lead drug candidate, PRO 2000 Gel. The product is designed to be used for the prevention of human immunodeficiency virus type 1 ( HIV -1) infecti
(BW) Two U.C. Berkeley Extension seminars to review recent research on HIV/AIDS and its clinical and psychosocial aspects: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 29 May 1997.; BERKELEY, Calif.--(BW HealthWire)--May 29, 1997--This summer, U.C. Berkeley Extension offers two seminars that focus on HIV /AIDS. The purpose of the first, Clinical and Psychosocial Aspects of HIV , is to inform clinicians about the medical, psychological and social aspects of HIV disease. Participants learn critical
(BW) (HARVARD-MIT/DR-DAVID-HO) 1996 Time Magazine 'Man of the Year,'Dr. David Ho, to speak at HST graduation: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 29 May 1997.; CAMBRIDGE, Mass.--(BW HealthWire)--May 29, 1997--Renowned Researcher Is 1978 Graduate of Select Harvard/MIT Program On Wednesday, June 4 from 1 to 3 p.m., Dr. David Ho, TIME magazine s 1996 Man of the Year will present the graduation address for the Harvard-MIT Division of Health Sciences and Technology (HST) at the MI
(BW) Gay Couples Often Ignored in HIV Prevention Efforts, But New UCSF Study Hopes to Bridge Gap: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday May 28 2:51 PM EDT; SAN FRANCISCO--(BUSINESS WIRE)--May 28, 1997--Gay male couples are often ignored in HIV prevention campaigns, according to UCSF researchers who are conducting the first study to assess reports of sexual behavior from both men in the couple. Seldom do prevention campaigns address gay men as part of a couple, said Tom Sl
(BW) (MEDTRADE) Medtrade '97 to address the growing demand for Home Test Kits at the first annual Test Kit/Diagnostics Expo: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 27 May 1997.; ATLANTA--(BW HealthWire)--May 27, 1997--One-of-a-kind expo to showcase the market s latest advancements in cost saving products for confidential and reliable home diagnostic testing Answering the call within a healthcare industry that is quickly looking to the advantages and cost savings associated with home test kits,
(BW) (PARTNERSHIP-IN-VISION) Partnership in Vision launches new web site; Low Vision Resources, CMV Retinitis Education & Treatment Information Available at http://www.piv.org: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; NEW YORK--(BW HealthWire)--May 23, 1997--Partnership in Vision (PIV), a collaboration of leading AIDS practitioners, advocates and vision specialists, today announced the premiere of its World Wide Web site (http://www.piv.org). The site is designed as a comprehensive educational resource for people with, and at risk f
(BW) EntreMed Inc. reports successful interim results in cancer Phase II clinical trials for thalidomide; Patient response at 50 percent in brain cancer and 60 percent in Kaposi's sarcoma (skin cancer); company also receives patent issuances for use of Thalidomide in angiogenic-medicated diseases: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 21 May 1997.; ROCKVILLE, Md.--(BW HealthWire)--May 21, 1997-- EntreMed Inc. (NASDAQ:ENMD) Wednesday announced successful interim results in brain cancer and Kaposi s sarcoma patients being treated with thalidomide in Phase II clinical trials . A 50-percent biological response in glioblastoma multiformae (brain cancer) patients curre
(BW) AmBisome approved in Brazil: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; BOULDER, Colo.--(BW HealthWire)--May 21, 1997--NeXstar Pharmaceuticals, Inc., (NASDAQ: NXTR) announced today that the Brazilian Ministry of Health has approved AmBisome (liposomal amphotericin B) for use in the treatment of systemic, or blood-borne fungal infections. The drug will be launched shortly through the compan
(BW) MGA Software announces latest version of ACSL BioMed for simulating clinical drug trials; Pharmacia & Upjohn Selects ACSL BioMed to Improve Clinical Trial Designs, Bring Drugs to Market Faster: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 19 May 1997.; CONCORD, Mass.--(BUSINESS WIRE)--May 19, 1997--In a move that will strengthen MGA Software Inc. s dominant presence in the clinical trial simulation market, the Company announced today the availability of ACSL BioMed 2.1. This latest version of ACSL BioMed, targeted to pharmacologists who are novice simulation software
(BW) (STANFORD-MED/AUTOIMMUNE) Improved treatment for autoimmune diseases: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 16 May 1997.; STANFORD, Calif.--(BW HealthWire)--May 16, 1997--The immune system adheres to a behavioral code that demands respect for the body s healthy cells and allows attack of only cancers and harmful microbial invaders -- usually. But sometimes immune cells break the rules and turn against normal parts of the body. When this h
(BW) XOMA receives broad patent for antifungal uses of BPI-derived products: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 15 May 1997.; BERKELEY, Calif.--(BW HealthWire)--May 15, 1997-- XOMA Corporation (NASDAQ:XOMA) today announced that it had received a new U.S. patent (No. 5,627,153, issued May 6, 1997), directed to the use of its pharmaceutical BPI protein products to treat fungal infections. The increasing incidence of systemic fungal infections,
(BW) (KAISER-PERMANENTE) Kaiser Permanente research finds no link between marijuana use and death: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 14 May 1997.; OAKLAND--(BUSINESS WIRE)--March 14, 1997--In an exhaustive study of ten years of mortality data for over 65,000 men and women, Kaiser Permanente research scientists found no statistically significant association between marijuana smoking and death. The study, entitled Marijuana Use and Mortality, is being published in
(BW) HIV home test sales allowed to continue in Kentucky: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 14 May 1997.; HOFFMAN ESTATES, Ill.--(BW HealthWire)--May 14, 1997--Drug stores, pharmacies and other retail outlets in Kentucky can continue to sell Home Access(R) HIV home test kits as a result of a judge s order entered in Franklin Circuit Court in Lexington, KY. The order enjoined enforcement of any Kentucky state law that would
(BW) (ILEX-ONCOLOGY/LEUKOSITE) ILEX Oncology and LeukoSite form joint venture to develop anti-leukemia compound: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 12 May 1997, 10:13 Eastern; SAN ANTONIO, Texas/CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 12, 1997-- ILEX(TM) Oncology, Inc. and LeukoSite Inc. today announced they have formed a joint venture to develop Campath-1H, a monoclonal antibody under development for the treatment of patients with chronic lymphocytic leukemia (CLL). CLL, the most prevalent f
(BW) (TROJAN-ULTRA-PLEASURE) Safer sex may never be the same! Introducing TROJAN ULTRA PLEASURE latex condoms: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 12 May 1997, 10:13 Eastern; NEW YORK--(BW HealthWire)--May 12, 1997-- America s No. 1 brand introduces a new condom designed to increase pleasure for both partners Safer sex may never be the same, now that TROJAN ULTRA PLEASURE(TM) latex condoms have hit the market. According to the makers of TROJAN(R), America s No. 1 condom brand, the new condo
(BW) (BIO-FLUORESCENT-TECH)(BFTK) Bio Fluorescent Technologies Inc. makes announcement: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 12 May 1997, 10:06 Eastern; SCOTTSDALE, Ariz.--(BW HealthWire)--May 12, 1997--Bio Fluorescent Technologies Inc. s (OTC BB:BFTK) agreement dated Feb. 11, 1997 to acquire all of the assets of Immune Network Research Ltd. (INR) has since been terminated. The company is exploring the possibility of licensing or otherwise acquiring from INR its rights
(BW) (UCSF/AIDS-FUNDING) Private funders often overlook valuable prevention programs, according to UCSF survey: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 8 May 1997, 13:27 Eastern; SAN FRANCISCO--(BW HealthWire)--May 8, 1997--Effective HIV prevention programs, such as condom distribution and needle exchange, are often overlooked by private funding agencies in the United States , according to a new UCSF survey of foundations that support HIV/AIDS prevention programs. In addition, the UCSF surv
(BW) (PROCEPT)(PRCT) Procept's topical microbicide against HIV shown to be contraceptive: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - MAY 8,1997 5:58 PACIFIC; CAMBRIDGE, Mass.--(BW HealthWire)--May 8, 1997-- Data Complement Anti-STD Activity Of PRO 2000 Gel Procept today announced preclinical results demonstrating the contraceptive efficacy of its PRO 2000 topical microbicide gel. In a program of late-breaking discoveries presented at the National Conference on Women and HIV
(BW) (PAGE-&-ASSOCIATES) Florida company first of its kind to earn viatical license in California: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 7 May 1997.; FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 7, 1997-- Florida-based Page and Associates, a viatical company that buys life insurance policies from terminally ill individuals, was recently licensed in California. It is the first licensed company that also offers the settlements as individual investments. Viatical compan
(BW) (GILEAD-SCIENCES)(GILD) Gilead Sciences begins human testing of oral PMPA for treatment of HIV; data from Phase I/II study of intravenous PMPA showed significant reduction of HIV: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 7 May 1997.; FOSTER CITY, Calif.--(BW HealthWire)--May 7, 1997-- Gilead Sciences Inc. (NASDAQ:GILD) announced today that it has begun enrolling patients in a Phase I/II study to evaluate the oral prodrug of PMPA (oral PMPA) for the potential treatment of human immunodeficiency virus (HIV) infection. This Phase I/II study is bei
(BW) (GILEAD-SCIENCES)(GILD) Gilead Announces Phase I/II Data Insufficient for Marketing Clearance of FORVADE Topical Gel to Treat Refractory Herpes in Patients With AIDS: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 6 May 1997.; FOSTER CITY, Calif.--(BW HealthWire)--May 6, 1997-- Gilead Sciences , Inc. (NASDAQ:GILD) announced today that the U.S. Food and Drug Administration ( FDA ) has determined that data from a placebo-controlled Phase I/II clinical study are not sufficient to support marketing clearance of FORVADE(TM) (
(BW) 3M Pharmaceuticals Announces New Treatment for Genital Warts Now Available in Pharmacy; Safe and Effective New Treatment Option for an Estimated 4 Million Americans Who Have Genital Warts: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 6 May 1997.; Aldara(TM) 5% cream, the first new therapeutic approach to the treatment of genital and perianal warts in five years, will be available in pharmacies nationwide by June 9. It is the first patient-applied immune response modifier* for the treatment of this sexually transmitted disease (STD). Discovered, manufactured and
(BW) Researchers' discovery of primitive protease may unlock mysteries of enzyme evolution: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; SAN FRANCISCO--(BW HealthWire)--May 5, 1997--Researchers at the San Francisco VA Medical Center and UC San Francisco have identified a primitive protease (an enzyme that cleaves proteins), that may hold the key to a better understanding of how enzymes evolved. Enzymes, which are protein catalysts, are critical to every
(BW) (BIOSOURCE-TECHNOLOGIES) Biosource Technologies, Inc. and SRI International Receive SBIR Award to Develop Novel Antiinflammatories: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 1 May 1997.; VACAVILLE, Calif.--(BW HealthWire)--May 1, 1997--Biosource Technologies, Inc., was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes for Allergy and Infectious Disease to develop melanin as a novel antiinflammatory compound. Biosource has a proprietary biomanufacturing techn
(BW) (PROVIDNC-HEALTH/ROSEHDGE) Providence and Rosehedge collaborate to serve AIDS patients: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 1 May 1997; SEATTLE--(BUSINESS WIRE)--May 1, 1997--Providence Health System and Rosehedge, the oldest AIDS housing and health care program in Washington State, have signed a preferred provider agreement. Through this agreement Providence will expand its services to include Rosehedge as the facility of choice for patients with HIV/
(BW) Gilead Sciences receives marketing authorization for VISTIDE in European Union; Pharmacia & Upjohn has exclusive rights: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 1 May 1997.; FOSTER CITY, Calif.--(BW HealthWire)--May 1, 1997-- Gilead Sciences , Inc. (NASDAQ:GILD) announced today that it has received marketing authorization for VISTIDE(R) ( cidofovir injection) from the European Commission (EC). This authorization allows the product to be marketed in all 15 countries of the Euro
(BW) "Love and Sex" storms the web; Hot and sexy web site offers tons of interactive information and things to do: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; NEW YORK--(BW HealthWire)--May 19, 1997--Where can you find lots of totally cool freebies like TROJAN(R) condoms , the one-and-only Date Genie who offers great dating advice, relationship surveys where your opinion about how to handle the opposite sex really counts, games that let you win fantastic prizes like a CD ste
(BW) Biocryst Pharmaceuticals begins HIV trial in humans with oral formulation of BCX-34: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; BIRMINGHAM, Ala.--(BW HealthWire)--April 30, 1997-- Preclinical Studies Support Novel Immunomodulatory Therapeutic Approach BioCryst Pharmaceuticals (Nasdaq: BCRX) today announced the initiation of a Phase I feasibility study using an oral formulation of its lead drug, BCX-34, for the treatment of HIV in combination wi
(BW) Empyrean Diagnostics announces marketing rights for unique product line in AIDS prevention: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 29 April 1997.; MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--April 29, 1997--Stephen D. Hayter, president and chief executive officer of Empyrean Diagnostics Ltd., announces that it has obtained the exclusive marketing rights in specific areas of the world, to two new products that can help prevent the transmission of infectious disease.
(BW) TheraTech reacquires certain marketing rights from SmithKline Beecham: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; SALT LAKE CITY and PHILADELPHIA--(BUSINESS WIRE)--April 28, 1997-- TheraTech Inc. (NASDAQ:THRT) and SmithKline Beecham (NYSE:SBH) Monday announced they have agreed that TheraTech will reacquire the marketing rights to its male testosterone patch in those countries where SmithKline Beecham is not currently marketing the
(BW) (NEW-YORK-CARES) FEATURE/Volunteers give of their time to "make a difference" and believe Elizabeth Taylor does this in her fight against AIDS: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -; NEW YORK--(BUSINESS WIRE FEATURES)--April 25, 1997--As President Clinton and Colin Powell get ready to call on America to volunteer in the President s Summit for America s Future, volunteers of the not-for-profit group New York Cares carry out this mission 365 days a year. New York Cares partnered with corporate sponso
(BW) (BERNARD-&-GLORIA-SALIK) World-Renowned French AIDS Scientist Dr. Luc Montagnier Named to Bernard & Gloria Salick Distinguished Professorship in Molecular & Cellular Biology at New York's Queens College; Record $4.5 Million Gift from Alumnus Largest in QC's history: Tenured Chair and Salick Family Center for Molecular & Cellular Biology: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 25 April 1997.; QUEENS, N.Y.--(BUSINESS WIRE)--April 25, 1997--A $4.5 million gift from Bernard and Gloria Salick will endow a new tenured professorship at Queens College/CUNY, with particular focus on HIV/AIDS and cancer, and also will provide initial funding to establish a major new research center in molecular and cellular biology.
(BW) VIMRX Successfully Completes Phase I Clinical Studies for VIMRxyn-R- --synthetic hypericin-- as Topical Phototherapy for Skin Diseases: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday April 25 8:39 AM EDT; WILMINGTON, DE--(BW Healthwire)--April 25, 1997-- -- Light-Activation Conditions Determined and Dose Ranges Selected; Company Planning Phase II Clinical Studies -- VIMRX Pharmaceuticals Inc today announced that it has successfully completed a Phase I clinical trial to evaluate VIMRxyn(R) (synthetic hypericin) as a topi
(BW) United States sues New York City for failing to filter Croton water supply: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 24 April 1997 4:40 PM EDT; NEW YORK--(BUSINESS WIRE)--April 24, 1997--Moving to protect public health under the Safe Drinking Water Act (SDWA), the United States today sued New York City for violating SDWA requirements by failing to filter drinking water from its Croton water supply. The Croton watershed, located just north of New York City, sup
(BW) (XOMA)(PFE) Data analysis does not support continuation of U.S. Phase III clinical trial for E5: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 24 April 1997.; BERKELEY, Calif.--(BUSINESS WIRE)--April 24, 1997-- XOMA Corporation (NASDAQ:XOMA) today announced that they and Pfizer Inc. (NYSE:PFE) have decided to discontinue the U.S. clinical trial of the E5(R) monoclonal antibody product as a treatment for gram-negative sepsis. Results of an interim analysis recently comple
(BW) Genta announces results published in The Lancet and IND approval for U.S. trial in non-Hodgkin's lymphoma: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday April 18 8:01 AM EDT; SAN DIEGO--(BW HealthWire)--April 18, 1997-- GENTA INC Friday announced that an article titled BCL2 antisense therapy in patients with non-Hodgkin s lymphoma will appear in the April 19 issue of The Lancet. The article describes interim results of a Phase I/IIa clinical trial using the company s antisense drug, G3139.
(BW) ImmuCell enters agreement to initiate FDA clinical trial of product to prevent Clostridium difficile-associated diarrhea: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday April 17 11:28 AM EDT; PORTLAND, Maine--(BW HealthWire)--April 17, 1997--ImmuCell Corporation (Nasdaq: ICCC; BSE:IMU) today announced that, under an Investigational New Drug ( IND ) application filed with the U.S. Food and Drug Administration earlier this year, it is preparing to conduct a clinical trial of its product, DiffGAM(TM) bovine an
(BW) (UCSF/BEHAVIORAL-SCIENCE) Behavioral Science should broaden research to address issues of new century, says UCSF expert: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 17 April 1997.; SAN FRANCISCO--(BW HealthWire)--April 17, 1997--Behavioral scientists should broaden their research agenda to include causes of death and disability that are on the rise, such as those due to injuries and infectious disease, according to nationally known behavioral scientist Margaret Chesney, PhD, co-director of the UC
(BW) (ALFACELL)(ACEL) Alfacell Presents at the American Association for Cancer Research; Data Further Elucidates the Cytotoxic and Anti-Proliferative Mechanism of Action of ONCONASE(R): BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 17 April 1997.; BLOOMFIELD, N.J.--(BUSINESS WIRE)--April 17, 1997 Scientists of Alfacell Corporation (NASDAQ: ACEL) presented today their latest research findings at the 88th American Association for Cancer Research (AACR) Annual Meeting in San Diego, further elucidating the mechanism of action of the Company s flagship product, ONCON
(BW) (SALIVA-DIAGNOSTIC)(SALV) European Union awards development grant for rapid TB test to KREATECH Biotechnology and Saliva Diagnostics Systems: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 15 April 1997.; VANCOUVER, Wash.--(BUSINESS WIRE)--April 15, 1997--A rapid test for tuberculosis (TB) may be developed through a half million ECU grant awarded by the European Union to Netherlands-based KREATECH Diagnostics and SDS International Ltd., a London-based, wholly owned subsidiary of Saliva Diagnostic Systems, Inc. (Nasdaq:
(BW) (HOME-ACCESS-HEALTH) Home Access Health announces retail agreement with Revco Drug Stores; Home Access expands national OTC availability for HIV-1 home test option: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 15 April 1997.; HOFFMAN ESTATES, Ill.--(BW HealthWire)--April 15, 1997--Home Access Health Corporation announced a retail distribution agreement with Revco D.S., Inc. (NYSE:RXR), one of the nation s largest drug retailers. The Home Access(R) and Home Access Express(R) HIV-1 test kits are being carried by Revco Drug Stores throughout s
(BW) HIV Viral Replication in Living Cells Blocked Using Eukarion Antibody Lipidation Technology: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 14 April 1997 9:01 AM EDT.; BEDFORD, Mass.--(BW HealthWire)--April 14, 1997--Eukarion, Inc. today announced that it has successfully blocked HIV-1 viral replication in living cells using a monoclonal antibody chemically modified to permit passage across cell membranes. A paper describing these results was published in the March issue of the Journ
(BW) (CHIRON)(CHIR) Chiron Submits Biological License Application For Proleukin - RECOMBINANT IL-2 - For Treatment of Metastatic Melanoma: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 14 April 1997 09:07 Eastern; EMERYVILLE, Calif.--(BUSINESS WIRE)--April 14, 1997--Chiron Corporation (NASDAQ:CHIR) announced today that it has submitted a supplemental Biological License Application (sBLA) to the United States Food and Drug Administration ( FDA ), seeking clearance to market Proleukin (aldesleukin, recombinant interleukin-2 (
(BW) FEATURE/Herb research may hold key to AIDS treatment; Independent Data Researcher May Have Found Key To AIDS Treatment: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday April 11 6:58 AM EDT; PACKWOOD, Wash.--(BUSINESS WIRE FEATURES)--April 11, 1997-- In an unusual and commendable research program, an ancient herbal formula is being redeveloped that may hold the key in the treatment of AIDS. Asclepias, named after Asklepios, the Greek god of healing, is now being used in the formulation of a special herbal
(BW) (GILEAD-SCIENCES)(GILD) Gilead's PMPA significantly reduces HIV levels in Phase I/II study; oral version expected to enter clinical trials soon: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 11 April 1997.; FOSTER CITY, Calif.--(BW HealthWire)--April 11, 1997-- Gilead Sciences , Inc. (NASDAQ:GILD) announced today data from a Phase I/II study demonstrating that the antiretroviral PMPA significantly reduced human immunodeficiency virus (HIV) RNA levels by greater than 90% after eight doses, with no significant side effects.
(BW) (BIOCHEM-PHARMA)(BCHXF) Phase III Clinical Data on Lamivudine for the Treatment of Hepatitis B: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 10 April 1997.; LONDON and LAVAL, Quebec--(BUSINESS WIRE)--April 10, 1997-- Glaxo Wellcome plc and BioChem Pharma Inc. announce that results from a Phase III clinical study of the investigational drug, lamivudine, in hepatitis B will be presented today in London, U.K., at the annual meeting of the European Associa
(BW) UCSF team to receive $4 million to explore ways to fight cancer by targeting tumor enzymes: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 9 April 1997.; SAN FRANCISCO--(BUSINESS WIRE)--April 9, 1997--The U.S. National Institutes of Health is awarding $4 million to fund cancer studies by researchers at the University of California San Francisco who are targeting tumor-made enzymes. These enzymes, called proteases, already have been successfully targeted with protease-in
(BW) CYTEL To Spin Off Vaccine Company: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 9 April 1997.; San Diego, Ca--(BUSINESS WIRE)--April 9, 1997--Cytel Corporation (Nasdaq:CYTL) today announced that it is restructuring operations and spinning off its vaccine program to form a new company. The new company will focus on novel vaccines for treatment and prevention of cancer and infectious diseases, capitalizing on the
(BW) Clinical data for Sequus Pharmaceuticals' Amphotect product indicate superior safety and efficacy in treating aspergillosis: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 8 April 1997.; MENLO PARK, Calif.--(BUSINESS WIRE)--April 8, 1997-- -- Data in April issue of peer-reviewed journal Clinical Infectious Diseases demonstrate that, as compared to amphotericin B, AMPHOTEC produces higher responses, lower mortality rates and greater renal safety in patients with invasive aspergillosis -- A retrospective
(BW) (ALLIED-BIOTECHNOLOGY)(ADBI) ADBI eliminates Hepatitis A and other viruses in food processing: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 8 April 1997.; IRVINE, Calif.--(BW HealthWire)--April 8, 1997--Allied Biotechnology International Inc. (OTC BB: ADBI) will be offering a free seminar via telephone on Tuesday, April 8, on the benefits of using the ADBI Ozonator to eliminate dangerous bacteria and viruses, such as Hepatitis A, in food handling and processing. The trag
(BW) (SF-AIDS-FOUNDATION) New AIDS Czar Appointed; Meaningful Responsibility and Close Access to President Necessary to Tackle Epidemic's Changes: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 7 April 1997.; SAN FRANCISCO--(BUSINESS WIRE)--April 7, 1997--The San Francisco AIDS Foundation applauds the appointment today of Sandra Thurman as the country s new AIDS czar and calls on President Clinton to grant her the access and authority she will need to tackle the dramatic new changes in the epidemic. President Clinton must g
(BW) TBS Superstations THE COMING PLAGUE Survey Reveals Limited Awareness of Infectious Disease in U.S.: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 7 April 1997.; ATLANTA--(BUSINESS WIRE)--April 7, 1997--In conjunction with TBS Superstations airing of THE COMING PLAGUE, a four-hour documentary series (airing April 20 & 27) about the state of infectious diseases in our world, the network has commissioned a consumer survey conducted by Marketing & Research Resources, Inc.
(BW) Fort Lauderdale company earns Florida's first viatical license: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 4 April 1997.; FORT LAUDERDALE, Fla.--(BW HealthWire)--April 4, 1997--Fort Lauderdale-based Page & Associates Thursday was issued Florida s first license to provide viatical settlements to Florida residents. Viatical companies provide accelerated life insurance settlements for terminally ill individuals and have been operating in
(BW) (STANFORD-MEDICAL-CENTER) In these T cells, HIV does no harm: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 2 April 1997; STANFORD, Calif.--(BW HealthWire)--April 2, 1997--Researchers have identified certain T cells that suppress the reproduction of HIV carried within them. These cells, called naive CD4 T cells, mount the body s initial response to infections such as HIV, the virus that causes AIDS. About half of all CD4 T cells circulati
(BW) (WASH-DEPT-OF-HEALTH) State Board of Health to hold public hearing on HIV/AIDS requirements: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 2 April 1997; OLYMPIA, Wash.--(BUSINESS WIRE)--April 2, 1997--The state Board of Health will meet April 9 to adopt new rules regarding HIV/AIDS, discuss telemedicine, vote on whether to allow optometrists to prescribe and administer non-topical drugs and hear a report on newborn screening. The meeting is open to the public. It will
(BW) Sequus Pharmaceuticals' Announces AMPHOTEC Results: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 1 April 1997; MENLO PARK, Calif.--(BUSINESS WIRE)--April 1, 1997--SEQUUS Pharmaceuticals, Inc. today announced results of a preclinical study comparing AMPHOTEC(TM) to amphotericin B and to alternative lipid-based formulations of amphotericin B. The study was conducted at the California Institute for Medical Research, Santa Clara Va
(BW) (CYBERCHEMICS-INC) CyberChemics Inc. founder presents two papers at ICANNGA: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 1 April 1997.; HUNTSVILLE, Ala.--(BW HealthWire)--April 1, 1997--CyberChemics Inc. (CCI) Tuesday announced the participation of scientists from the company, including one of its founders, Dr. David Noever, at the International Conference on Artificial Neural Networks and Genetic Algorithms (ICANNGA), a biannual meeting of the computa
(BW) (HEMOCLEANSE) HemoCleanse receives approval of "CE" Mark for sale of products in Europe: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 1 April 1997; WEST LAFAYETTE, Ind.--(BW HealthWire)--April 1, 1997-- HemoCleanse Inc. announced that it has received approval and authorization from TUV Product Service, their European Notified Body, to put the CE Mark on the labeling of its BioLogic-DT Machine and disposable Treatment Kit. The CE Mark, recognized worldwide as an as
(BW) Dignity Partners announces earnings, sale of policies, sale of equity investment and cessation of viatical settlement business: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday March 31 5:00 PM EDT; SAN FRANCISCO--(BUSINESS WIRE)--March 31, 1997-- Dignity Partners Inc today reported a net loss of $9.7 million (or ($2.46) per share based on 3,942,166 weighted average outstanding shares) for the year ended Dec. 31, 1996, compared to net income of $803,000 (or $.42 per share based on 1,902,482 outstanding shares) for
(BW) XOMA leveraging its high-yield recombinant pharmaceutical production assets; Technology already licensed to eight biotech and pharma companies worldwide: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 31 March 1997; BERKELEY, Calif.--(BW HealthWire)--March 31, 1997-- XOMA Corporation (NASDAQ:XOMA) is actively licensing its proprietary technology for the recombinant production of biopharmaceutical products. XOMA s bacterial cell expression system uses its patented genetic engineering technologies with proprietary fermentation proce
(BW) (PROCEPT)(PRCT) Procept receives patent for novel method of inhibiting HIV infection; U.S. patent covers topical administration of PRO 2000: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 31 March 1997.; CAMBRIDGE, Mass.--(BW HealthWire)--March 31, 1997--Procept, Inc. (Nasdaq: PRCT) announced today that it has been issued Patent No. 5,614,559 for the use of PRO 2000 gel, a topical microbicide it is developing as a chemical barrier to prevent HIV infection and other STDs (sexually transmitted diseases). This patent cove
(BW) (UCSF/CAPS) UCSF AIDS researchers begin coping study -- participants needed: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 28 March 1997.; SAN FRANCISCO--(BW HealthWire)--March 28, 1997--Researchers at the UCSF Center for AIDS Prevention Studies (CAPS) have begun a new study to examine how gay men living with HIV are handling all of the new stresses of the changing epidemic. Due to major changes in available treatments, new challenges have emerged in the
(BW) (HOME-ACCESS/WAL-MART) Home Access Health announces retail agreement with Wal-Mart Stores: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 27 March 1997.; HOFFMAN ESTATES, Ill.--(BW HealthWire)--March 27, 1997-- Home Access Expands National OTC Availability For HIV-1 Home Test Option Home Access Health Corporation announced a retail distribution agreement with Wal-Mart Stores, Inc. (NYSE: WMT), the largest retailer in the world. The Home Access(TM) and Home Access Expres
(BW) Patients, doctors routinely exposed to disease in surgery, new technology would greatly reduce the risk: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 26 March 1997.; SAN DIEGO--(BW HealthWire)--March 26, 1997--Despite high standards for infection control within hospitals, millions of U.S. patients and health care workers each year contract life-threatening diseases, such as AIDS, hepatitis B and C and other infectious diseases. One of the reasons may be because health care work
(BW) (MEDICAL-DEVICE-TECH-2)(MEDD) Studies commissioned by Medical Device Technologies validate need for surgical latex-glove monitoring: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 26 March 1997.; SAN DIEGO--(BW HealthWire)--March 26, 1997-- Fluid Alarm System monitoring device reduces risks for passage of deadly viruses through latex gloves Medical Device Technologies Inc. (NASDAQ:MEDD,MEDDP,MEDDW) announced the results of three separate parallel studies commissioned by the company on the saturation of surgical
(BW) (SHAMAN-PHARMACEUTICALS)(SHMN) Shaman Pharmaceuticals initiates AIDS diarrhea trial and completes first of series of dose-optimization studies for traveler's and non-specific diarrhea: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 26 March 1997.; SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--March 26, 1997-- Shaman Pharmaceuticals, Inc. (NASDAQ:SHMN) announced today that it has expanded its Phase II program for Provir, an oral product for the treatment of diarrhea, to conduct a pilot study that tests Provir for diarrhea in patients with AIDS. The double-blind,
(BW) (CHIRON)(CHIR) Chiron Vision's Vitrasert implant is cleared for marketing in European Union: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 25 March 1997.; EMERYVILLE, Calif.--(BW HealthWire)--March 25, 1997--Chiron Vision, a business of Chiron Corporation (NASDAQ:CHIR), announced today that the European Commission has granted a marketing authorization for the Vitrasert (TM) Implant in all 15 countries of the European Union. The market clearance follows a recommendati
(BW) Tuberculosis declines, but disease continues to be a concern: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 24 March 1997.; OLYMPIA, Wash.--(BUSINESS WIRE)--May 24, 1997--Though the incidence of new tuberculosis cases has dropped 16 percent in Washington since 1991, the disease remains a concern. Many people may not know they are infected with the disease. Today is World TB Day, an opportunity to build awareness. Effective cures have b
(BW) (CHIRON)(CHIR) NIH Study Shows IL-2 Immunotherapy Boosts Immune Cell Levels in HIV-Infected Patients; Convenient Subcutaneous Dosing Regimen Characterized: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 24 March 1997.; EMERYVILLE, Calif.--(BW HealthWire)--March 24, 1997--Chiron Corporation (Nasdaq:CHIR) today announced that, according to a study reported in the April issue of the Journal of Infectious Diseases by Richard Davey, M.D., Clifford Lane, M.D. and their colleagues at the National Institutes of Health (NIH), outpatient subcu
(BW) (GERN) Geron and Pharmacia & Upjohn announce signing of agreement to develop new class of anticancer drugs: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 24 March 1997.; MENLO PARK, Calif.--(BW HealthWire)--March 24, 1997--Geron Corporation (NASDAQ:GERN) and Pharmacia & Upjohn (NYSE:PNU) today announced that they have signed a definitive agreement to collaborate in the discovery, development and commercialization of a new class of anticancer drugs that inhibit telomerase, an enzym
(BW) (ZILA) Zila to market OraTest in Republic of China: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 24 March 1997.; PHOENIX--(BW HealthWire)--March 24, 1997--Zila Inc. (NASDAQ:ZILA), international provider of oral healthcare products for dental/medical professionals and consumers, announced that marketing of its oral cancer detection system, OraTest(TM), will begin in May in the Republic of China (
(BW) (RPT/BROWN-&-TOLAND) REPEAT/Brown & Toland Medical Group offers background information on health topics: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 21 March 1997.; SAN FRANCISCO--(BW HealthWire)--March 21, 1997--The Brown & Toland Medical Group has recently compiled background information on the following topics: -0- Disease Management Programs -- HIV -- Asthma -- Geriatrics -- Congestive Heart Failure After-Hours Pediatric Care Wellness Programs Please let us know if we c
(BW) (TENNESSEE-MEDICAL-ASSOC) Physician Magazine Takes Close Look at the Tuberculosis in Tennessee: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 21 March 1997.; NASHVILLE, Tenn.--(BUSINESS WIRE)--March 21, 1997--Contrary to reports of recent outbreaks in Tennessee, tuberculosis or TB, still the leading infectious disease killer in the world, has declined in recent years. In fact, according to a new article published this week in Tennessee Medicine: The Journal of the Tennessee
(BW) (ENZO-BIOCHEM)(ENZ) Enzo files U.S. patent application for compound and novel procedure to selectively regulate immune system: BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 20 March 1997.; FARMINGDALE, N.Y.--(BUSINESS WIRE)--March 20, 1997-- Potential wide application includes infectious disease management, gene therapy and organ transplantation Enzo Biochem Inc. (ASE:ENZ) announced today the filing of a U.S. patent application for a compound and novel procedure that could allow for the management of und
(BW) (MEDICAL-DEVICE-TECH) Latex gloves worn for surgeries routin